Close Menu

Wellcome Sanger Institute

For-profit organizations will be charged an annual fee to download COSMIC content that will vary depending on the organization's size and manner of using the resource.

Researchers identified a form of ultra-hypermutated cancer that occurs in individuals with inherited and somatic mutations in their DNA repair machinery.

The partners are the Wellcome Trust Sanger Institute, The Innovative Genomics Initiative, Thermo Fisher Scientific, and the Broad and Whitehead Institutes.

The researchers analyzed variants in more than 1,100 children with severe undiagnosed developmental disorders and their parents using exome sequencing and array-CGH data.

Researchers report that Plasmodium falciparum shuffles its antigen genes in an apparent bid to avoid detection by the host immune system.

The deal will give scientists at the Single Cell Genomics Centre access to Fluidigm's newest equipment and methods and will create new bioinformatics tools.

Using arrays and exome sequencing, the study aims to diagnoses children with previously undiagnosed developmental disorders.

The Sanger Institute spin-off will use its sequencing and bioinformatics services to link genomic and clinical outcomes data for patient stratification.

Using genome sequencing, a team has characterized and tracked methicillin-resistant Staphylococcus aureus isolates at a high-transmission hospital in Thailand.

The study shines light on the population history of sub-Saharan Africa and provides the basis for future medical genetics studies, including a new pan-African genotype array.


The first reported coronavirus cases in Europe and the US might not be related to the subsequent outbreaks in those areas, according to the New York Times.

According to NPR, there's a growing shortage of machines to run SARS-CoV-2 tests.

The Wall Street Journal and Kaiser Health News report that antibody testing for SARS-CoV-2 has led to further confusion.

In Nature this week: the largest known collection of human genetic variants, and more.